database, especially BMI, is a major limitation of the study. Even when authors try to ascertain COPD and alcohol related illnesses as proxies for smoking and alcohol consumption respectively, there is a high likelihood of residual confounding. Since both comments (1) and (2) are related, and probably cannot be addressed in an insurance claims database, both these points should be added to the limitations paragraph in the discussion section. Moreover, since they are major limitations, I think that also should be mentioned in a sentence in the abstract.
(3) Should the primary outcome include asymptomatic gallstone disease cases, or just use symptomatic gallstone disease cases? : Use of medical diagnosis code (ICD 574) would yield cases of both symptomatic as well as asymptomatic gallstone disease. Inclusion of asymptomatic cases in the case group has several problems: 3a) There is no routine screening of asymptomatic gallstone disease and a vast majority of these individuals remain undiagnosed. The small percentage of asymptomatic gallstone cases that get diagnosed are probably a result of incidental diagnosis on abdominal imaging due to some other condition. There will be many non-cases in this study that would also have asymptomatic gallstones that did not get diagnosed because they did not have abdominal imaging, or did have imaging but the presence of these gallstones were not noted in the insurance claims data because no treatment was required. Thus there is a high potential for outcome misclassification. 3b) Inclusion of asymptomatic gallstone cases in the outcome group could inadvertently tag the underlying indications of abdominal imaging -for e.g. patients with liver disease/ NAFLD/ NASH are more likely get diagnosed with incidental gallstones than patients without these morbidities. This could also explain some of the unexpected associations seen in table 2.
It seems to me that the clinically relevant, and clean outcome is symptomatic gallstone disease -for which procedure code for cholecystectomy would be a reasonable proxy, as opposed to the medical diagnosis code. Additional advantage of the using the cholecystectomy procedure code would be that it would minimize misclassification of outcome -i.e. most cases will truly have symptomatic gallstone disease and most non-cases will not. It is suggested that that authors should use a surgical procedure code for laparoscopic/ open cholecystectomy to define the primary outcome, and redo the association analysis. Asymptomatic cases can be included as secondary analysis but because of the problems listed above they should be excluded from the primary analysis. Minor comments:
(1) The authors have used the abbreviation 'HD' at multiple places (e.g. in the conclusion paragraph -page 18, line 46), without stating what it stands for. The Authors conducted a nationwide population-based cohort study to determine the association between Hashimoto's thyroiditis (HT) and the subsequent development of cholelithiasis. They hypothesized that HT per se could be associated with an increased risk of cholelithiasis. Futhermore, hypothyroidism is a well-known risk factor for cholelithiasis but the association between HT and cholelithiasis has never been discussed before in the literature.
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The study examined an HT cohort of 1268 patients and a non-HT cohort. The age-specific relative risk of cholelithiasis in the HT cohort was higher than that in the non-HT cohort for patients aged above 65 years, and the sex-specific relative risk of cholelithiasis in the HT cohort was higher than that in the non-HT cohort for women. These findings confirmed an increased risk of cholelithiasis after HT diagnosis; however, the Authors could not establish the causal relationship between HT and cholelithiasis in that study. Moreover, the Authors tried to explain the possible pathophysiological mechanisms underlying the development of cholelithiasis after HT diagnosis. Reply: Many thanks for the reviewer's commet and we have included this inherent limitaion of our retrospective study to our final limitation.
Please refer to the final limitation. Finally, the definite pathophysiology and the causal relationship for the association between HT and cholelithiasis could not be ascertained in this observational study and it requires more studies to clarify the relationship. However, the association could not be simply explained by hypothyroidism. HT per se might be associated with development of cholelithiasis was supported by our findings that the association persisted in multivariable Cox proportional hazard regression model after controlling the confounding factors, including hyperthyroidism and hypothyroidism, Furthermore, with comparable aHRs, HT patients with and without thyroxine treatment were similarly associated with a higher risk of cholelithiasis than those in the non-HT cohort.
Strong points of that study: 1. Innovative research project 2. Appropriate design of the study 3. Clearly defined inclusion and exclusion criteria for study population 4. Clear and logical presentation of the results with graphics and table 5. One -Center -study 6. Good statistical processing of data 7. Interesting conclusions of the study Reply: Many thanks for the reviewer's comment and we have tried to included these strong points to the Strenths and Limitations section.
Please refer to the strengths section.
The strengths of our study are its population-based design, use of a single administrative database analysis with NHIRD records, and generalizability of findings with a very large sample size including study and control cohorts.
This study is the first study to demonstrate the association between Hashimoto's thyroiditis and cholelithiasis. Moreover, the association is validated by the association between cholecystectomy and Hashimoto's thyroiditis in our study. The results of the study are interesting from the scientific and practical point of view.
Reply: Many thanks for the reviewer's comment and we have tried to included these weak points to the Strenths and Limitations section. Moreover, we have added these references accordingly.
Please refer to the limitations section:
The retrospective cohort study is subject to many biases related to the necessary adjustments for confounding factors.
The evidence derived from a retrospective cohort study is generally of lower methodological quality than that from randomized trials, and the causal relationship of HT to cholelithiasis and cholecystectomy could not be ascertained in this study.
Hypothyroidism is a well-known risk factor for cholelithiasis, particularly for GSD. However, not all the patients will develop hypothyroidism, they sometimes present euthyroid or hyperthyroid features (15). It has been reported that either euthyroidism or subclinical hypothyroidism HT children frequently evolved towards clinical hypothyroidism, whereas those presenting with overt hyperthyroidism always had definitive resolution of hyperthyroid and even evolved towards euthyroidism or hypothyroidism (16, 17) . This study uses claims data from the National Health Insurance Research Database in Taiwan to investigate whether Hashimoto's thyroiditis (HT) is associated with cholelithiasis. The authors observe that HT is associated with an increased risk of cholelithisais, with an HR of 1.9. There was no evidence that this association is heterogeneous by gender or by thyroxine treatment status. This study attempts to answer an important question in a nation-wide cohort, the statistical approach is sound, and the findings are intriguing.
However, there are major concerns -particularly related to inability to ascertain covariate data and to adequately account for confounding bias.
(1) Misclassification of important covariates: Insurance claims data tend to be inconsistent in the frequency with which the diagnosis is entered by the care providers. It is very likely that medical conditions that require treatment are reported more frequently, compared to conditions which have no associated therapy. For example in Non-random misclassification could bias effect estimates away from the null.
(2) Residual confounding: The strongest risk (or protective) factors for cholelithiasis include high BMI, postmenopausal hormones, recent weight loss, dietary factors, coffee intake, smoking, alcohol, history of type 2 diabetes, hypertension and dyslipidemia. Many of these factors could not be ascertained at all from the insurance claims database (e.g. post menopausal hormone use, diet, coffee, alcohol, smoking, etc. ), and some could only be ascertained partially (e.g., obesity instead of BMI). It is well established that obesity is not necessary, any increase in BMI is linearly associated with cholelithiasis even among normal weight individuals. The inability to obtain information on these variables in the claims database, especially BMI, is a major limitation of the study. Even when authors try to ascertain COPD and alcohol related illnesses as proxies for smoking and alcohol consumption respectively, there is a high likelihood of residual confounding. Since both comments (1) and (2) are related, and probably cannot be addressed in an insurance claims database, both these points should be added to the limitations paragraph in the discussion section. Moreover, since they are major limitations, I think that also should be mentioned in a sentence in the abstract. Reply: Many thanks for thr reviewer's comment and we have added these limitations to the 1st limitation, the 3rd limitation, and the abstract.
Please refer to the 1st limitation, the 3rd limitation, and the conclusions of abstract section.
Firstly, the evidence derived from a retrospective cohort study is generally of lower methodological quality than that from randomized trials since the retrospective cohort study is subject to many biases related to the necessary adjustments for confounding factors. Many of these factors could not be ascertained at all from the insurance claims database (e.g. post menopausal hormone use, diet, coffee, alcohol, smoking, etc. ) and some could only be ascertained partially (e.g. obesity instead of body mass index) even though we have used the diagnosis of COPD and alcohol-related illness as replacements for the habits of smoking and alcohol consumption, respectively.
Thirdly, the association between HT and cholelithiasis might be skewed by the surveillance bias since the patients with HT would get more opportunities of abdominal imaging studies or the presence of cholelithiasis was not recorded in the insurance claims data because no treatment was required. However, the association has been supported by the association between cholecystectomy and HT in our study although asymptomatic cholelithiasis and cholecystectomy might be different entities.
Conclusions: Inability to obtain information on several potential confounding factors and misclassification of important covariates are the major limitation of the study. Our study indicates HT per se was associated with the development of cholelithiasis, which has been validated by the association between cholecystectomy and HT. The surveys and health education on cholelithiasis in women aged  50 years with HT should be considered by clinicians and that further prospective research should be done on this topic.
(3) Should the primary outcome include asymptomatic gallstone disease cases, or just use symptomatic gallstone disease cases? : Reply: Many thanks for the reviewer's comment. Primary outcome included either asymptomatic or symptomatic cholelithiasis and we also assessed the association between cholecystectomy and HT to validate the aforementionaed association.
Please refer to Table 5 . Use of medical diagnosis code (ICD 574) would yield cases of both symptomatic as well as asymptomatic gallstone disease. Inclusion of asymptomatic cases in the case group has several problems: 3a) There is no routine screening of asymptomatic gallstone disease and a vast majority of these individuals remain undiagnosed. The small percentage of asymptomatic gallstone cases that get diagnosed are probably a result of incidental diagnosis on abdominal imaging due to some other condition. There will be many non-cases in this study that would also have asymptomatic gallstones that did not get diagnosed because they did not have abdominal imaging, or did have imaging but the presence of these gallstones were not noted in the insurance claims data because no treatment was required. Thus there is a high potential for outcome misclassification. Reply: Many thanks for the reviewer's comment and we have added this point to the 3rd limitation.
Please refer to the 3rd limitation. Thirdly, the association between HT and cholelithiasis might be skewed by the surveillance bias since the patients with HT would get more opportunities of abdominal imaging studies or the presence of tcholelithiasis was not noted in the insurance claims data because no treatment was required. However, the association has been supported by the association between cholecystectomy and HT in our study although asymptomatic cholelithiasis and cholecystectomy might be different entities.
3b) Inclusion of asymptomatic gallstone cases in the outcome group could inadvertently tag the underlying indications of abdominal imaging -for e.g. patients with liver disease/ NAFLD/ NASH are more likely get diagnosed with incidental gallstones than patients without these morbidities. This could also explain some of the unexpected associations seen in table 2. Reply: Many thanks for thr reviewer's comment and we have added this issue in the revised manuscript.
However, a possible surveillance bias was raised because patients with comorbidities are more likely get diagnosed with incidental cholelithiasis than patients without these morbidities. The inclusion of asymptomatic cholelithiasis in the outcome group could inadvertently tag more indications of abdominal imaging and, therefore, lead to unexpected associations between some comorbidities with cholelithiasis.
It seems to me that the clinically relevant, and clean outcome is symptomatic gallstone disease -for which procedure code for cholecystectomy would be a reasonable proxy, as opposed to the medical diagnosis code. Additional advantage of the using the cholecystectomy procedure code would be that it would minimize misclassification of outcome -i.e. most cases will truly have symptomatic gallstone disease and most non-cases will not. It is suggested that that authors should use a surgical procedure code for laparoscopic/ open cholecystectomy to define the primary outcome, and redo the association analysis. Asymptomatic cases can be included as secondary analysis but because of the problems listed above they should be excluded from the primary analysis. Reply: Many thanks for the reviewer's comment. Primary outcome included either asymptomatic or symptomatic cholelithiasis and we also assessed the association between cholecystectomy and HT to validate the aforementionaed association.
Please refer to Table 5 . In this observational study Chen et al. investigate the relationship between Hashimoto's thyroiditis (HT) and cholelithiasis. It appears to be a well-executed and well-written study and of interest to few different specialists.
Major comments: - Table 1 : I do not understand how hyperthyroidism incidence is higher comparative to hypothyroidism in the HT cohort. Hyperthyroidism in this context (the so-called hashitoxicosis) is meant to be quite rare. Are you sure you have not included patients with Graves' disease or other hyperthyroidism pathologies? Reply: Of the 367 patients of the HT cohort with a history of hyperthyroidism, 171 (46.6%) patients had history of Grave's disease (GD) before evolving to HT. Of the 96 patients of non-HT cohort with a history of hyperthyroidism, 41 (42.7%) patients had history of GD.
-The other major limitation that has been correctly highlighted by the authors is the observational/retrospective nature of this study which does not allow for defining causation Reply: Many thanks for thr reviewer's comment and we have added these limitations to the 1st limitation, the 3rd limitation, and the abstract.
Thirdly, the association between HT and cholelithiasis might be skewed by the surveillance bias since the patients with HT would get more opportunities of abdominal imaging studies or the presence of cholelithiasis was not noted in the insurance claims data because no treatment was required. However, the association has been supported by the association between cholecystectomy and HT in our study although asymptomatic cholelithiasis and cholecystectomy might be different entities.
Minor comments: -Pg8 Line 10: check wording to 'an autoiommune process' Reply: Many thanks for the reviewer's comment and we have corrected the wording.
-Pg11: since you mentioned that coding took place as per ICD-9-CM criteria I am not convinced that the specific codes for each disease need to appear on the actual text Reply: Many thanks for the reviewer's commet and we have revised the text concisely.
-Pg16: I am not sure what the abbreviation HD means; is it simply a mistake and is meant to be HT? Please review and in the rest of the text Reply: Many thanks for the reviewer's comment and we have corrected the wordings to be "HT".
-Pg 17 / line 32: replace 'co-morbidity' with 'a co-morbidity' Reply: Many thanks for the reviewer's comment and the wording has been corrected.
-Pg 18-19: 'first', 'second' etc. -better replace with 'firstly, 'secondly' and so on Reply: Many thanks for the reviewer's comment and we have revised the wordings accordingly.
-Pg19 / line 40: I think it will make more sense to say 'and HT in patients with and without ..' Reply: Many thanks for the reviewer's comment and we have revsied these sentences.
However, the association could not be simply explained by hypothyroidism. HT per se might be associated with development of cholelithiasis was supported by our findings that the association persisted in multivariable Cox proportional hazard regression model after controlling the confounding factors, including hyperthyroidism and hypothyroidism, Furthermore, HT patients with and without thyroxine treatment were similarly associated with a higher risk of cholelithiasis than those in the non-HT cohort and their aHRs were comparable.
-Pg 19-20 -last sentence: You have not proven that screening of HT patients for cholelithiasis should be done, hereby it is a bit of an overstatement to recommend it. Maybe say it should be considered by clinicians and that further prospective research should be done on this topic. Reply: Many thanks for the reviewer's comment and we have revised the conclusion.
In conclusion, our population-based cohort study demonstrated HT per se was associated with the development of cholelithiasis, particularly in women aged  50 years. The risk of cholelithiasis increased with the follow-up time after a diagnosis of HT. The surveys and health education on cholelithiasis in women aged  50 years with HT should be considered by clinicians and that further prospective research should be done on this topic. The aforementioned association has been been validated by the association between cholecystectomy and HT. However, inability to obtain information on several potential confounding factors and misclassification of important covariates are the major limitation of the study.
-Table3: maybe briefly comment on some of the negative findings of the study; e.g. is the reason there is no relationship between male gender and age<65yrs with increased cholelithiasis incidence in HT patients due to the smaller study populations of these sub-groups? Reply: The reasons for no relationship between male gender and age <50 yrs with increased cholelithiasis incidence in HT patients might be due to the smaller study populations of of men (N = 127) and smaller case number of cholelithiasis (44/913), respectively (Table 3 ).
-Why do you think the use of thyroxine does not seem to ameliorate the increased incidence of cholelithiasis for HT and what can we deduce from this? Reply: The use of thyroxine does not seem to ameliorate the increased incidence of cholelithiasis for HT since HT patients with (aHR = 1.94, 95% CI = 1.51-2.49) and without (aHR = 1.95, 95% CI = 1.53-2.49) thyroxine treatment were similarly associated with a higher risk of cholelithiasis than those in the non-HT cohort and their aHRs were comparable (Table 4 ). These findings support that the association between HT and cholelithiasis might not simply be relevant to the thyroid function. The authors have answered all my comments. Notwithstanding, I am still concerned regarding the inclusion of a large number of Graves' disease and other hyperthyroidism causes. The authors claim that these are cases that switched to Hashimoto's thyroiditis (HT) and recorded as such in the insurance database. I suspect that these are indeed patients with Graves's disease all along; these often have positive antibodies (e.g. TPO) and sonographically have chronic inflammatory features that are difficult to separate form HT. In other words, the 'experimental group' seems to be a more varied autoimmune thyroid disease group than what we would conventionally call HT.
Reply: Many thanaks for the reviewer's reminding and we found that HT was consistently asscociated with the risk of cholelithiasis or cholecystectomy even though we have excluded the 171 patients with a history of GD from the HT cohort.
Please refer to Lines 6-9 on Page 13 of Results section, Lines 14-16 on Page 14 of Results section, and the third limitation of Discussion section on Page 20. HT was found to be consistently associated with the development of cholelithiasis (aHR = 1.96, 95% CI = 1.60-2.40) after we excluded the 171 patients with a history of GD from the HT cohort to avoid enrolling a more varied autoimmune thyroid disease group into the HT cohort (data not shown).
Similarly, HT was consistently associated with the risk of cholecystectomy (aHR = 1.33, 95% CI = 1.05-1.69) after we excluded the 171 patients with a history of GD from the HT cohort (data not shown).
Thirdly, the 171 patients with a history of GD before evolving to HT might belong to a heterogenous autoimmune thyroid disease group, rather than conventionally defined HT, since they often had positive antibodies and chronic inflammatory features in sonography that are difficult to differentiate form HT. However, HT was consistently asscociated with the risk of cholelithiasis or cholecystectomy even though we have excluded the 171 patients with a history of GD from the HT cohort. 
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